The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease

T Seeger-Nukpezah, DM Geynisman… - Nature Reviews …, 2015 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is a progressive inherited disorder
in which renal tissue is gradually replaced with fluid-filled cysts, giving rise to chronic kidney …

Selective targeting of the stress chaperome as a therapeutic strategy

T Taldone, SO Ochiana, PD Patel, G Chiosis - Trends in pharmacological …, 2014 - cell.com
Normal cellular function is maintained by coordinated proteome machinery that performs a
vast array of activities. Hel** the proteome in such roles is the chaperome, a network of …

Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease

L Chen, X Zhou, LX Fan, Y Yao… - The Journal of clinical …, 2015 - jci.org
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by renal cyst
formation, inflammation, and fibrosis. Macrophages infiltrate cystic kidneys, but the role of …

Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease

LX Li, LX Fan, JX Zhou, JJ Grantham, JP Calvet… - The Journal of clinical …, 2017 - jci.org
Autosomal dominant polycystic kidney disease (ADPKD) is driven by mutations in PKD1 and
PKD2 genes. Recent work suggests that epigenetic modulation of gene expression and …

Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model

P Zhu, CJ Sieben, X Xu, PC Harris… - Human molecular …, 2017 - academic.oup.com
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in either
PKD1 or PKD2. It is one of the most common heritable human diseases with eventual …

Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans

C Li, J Tu, G Han, N Liu, C Sheng - European journal of medicinal chemistry, 2022 - Elsevier
Clinical treatment of candidiasis has suffered from increasingly severe drug resistance and
limited efficacy. Thus, novel strategies to deal with drug resistance are highly desired to …

Renal ciliopathies: promising drug targets and prospects for clinical trials

L Devlin, P Dhondurao Sudhindar… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Renal ciliopathies represent a collection of genetic disorders characterized by
deficiencies in the biogenesis, maintenance, or functioning of the ciliary complex. These …

Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD

X Zhou, LX Fan, DJM Peters, M Trudel… - Human molecular …, 2015 - academic.oup.com
In this study, we identified a BET bromodomain (BRD) protein, Brd4, not only as a novel
epigenetic regulator of autosomal dominant polycystic kidney disease (ADPKD) but also as …

HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3

N Mahendrarajah, ME Borisova, S Reichardt… - Cellular signalling, 2017 - Elsevier
Signal transducers and activators of transcription (STATs) are latent, cytoplasmic
transcription factors. Janus kinases (JAKs) and activated CDC42-associated kinase-1 …

The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease

A Kurbegovic, M Trudel - Cellular Signalling, 2020 - Elsevier
The transcription factors Myc and p53 associated with oncogenesis play determinant roles in
a human genetic disorder, autosomal dominant polycystic kidney disease (ADPKD), that …